Document is current
Any future updates will be listed below
-
Authors
Bednarz, Aleksandra
Kożuch, Paweł
Kowalski, Kacper
Skulimowska, Izabella https://orcid.org/0000-0001-7620-6089
Kachamakova-Trojanowska, Neli https://orcid.org/0000-0002-3226-0726
Filipek-Gorzała, Jadwiga
Kwiecińska, Patrycja https://orcid.org/0000-0002-2632-4025
García-García, Raquel
Gawlińska, Kinga https://orcid.org/0000-0001-7015-154X
Mależyna, Kinga
Kubiak, Andrzej
Bryniarska-Kubiak, Natalia
Józkowicz, Alicja https://orcid.org/0000-0002-7317-260X
Szade, Krzysztof https://orcid.org/0000-0002-7227-4276
Szade, Agata https://orcid.org/0000-0002-0575-4659
-
Funding
Funding for this research was provided by:
Narodowe Centrum Badań i Rozwoju (LIDER/37/0133/L-11/19/NCBR/2020)
- License Information
-
More Information
Article History
Received: 2 April 2025
Revised: 22 May 2025
Accepted: 5 June 2025
First Online: 9 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: AJ, AS, and KS are co-inventors of the patents US10010557 and US10328085: Cobalt Porphyrins for the Treatment of Blood-Related Disorders and EP 3139917: Cobalt Protoporphyrin IX for the Treatment of Blood-Related Disorders, granted to Jagiellonian University. The remaining authors declare no conflict of interest.
